DUBLIN, Ireland, October 21, 2013 /PRNewswire/ --
Research and Markets
( http://www.researchandmarkets.com/research/ssfwwf/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.
This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments:
The report profiles 69 companies including many key and niche players such as:
Key Topics Covered: Click the link below to view the full extended table of contents and list of companies featured.
I. Introduction, Methodology & Product Definitions
II. Executive Summary
1. Industry Overview
2. Growth Drivers & Trends
3. Market Challenges
4. Therapeutic Radiopharmaceutical Products Under Development
5. Imaging Agents - An Overview
6. Nuclear Medicine - An Overview
7. Product Overview
8. Product Innovations/Introductions
9. Product Innovations/Introductions In Recent Past- A Perspective Builder
10. Recent Industry Activity
11. Corporate Activity In The Recent Past - A Perspective Builder
12. Focus On Select Players
13. Global Market Perspective
1. The United States
6. Middle East
7. Latin America
IV. Competitive Landscape
Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79)
For more information visit http://www.researchandmarkets.com/research/ssfwwf/radiopharmaceutica
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved